Skip to main content

Container Content Reference Corrections in Monographs and General Chapter

Type of Posting: Publication Correction

Posting Date: 27–Jan–2012

USP is alerting stakeholders that references to the Volume in Container section of General Chapter <1> Injections will be changed to refer to the Container Content section to be consistent with a recent change made in General Chapter <1> Injections. These references will be changed in fifty-eight monographs and one General Chapter.

In 2009, the Parenteral Products-Industrial Expert Committee proposed adding text that provided guidance for determining the volume in container for sterile solid formulations, which was absent from the compendia. To correctly label the section and include sterile solid formulations, the Expert Committee proposed changing the section title “Volume in Container” to “Container Content.” The proposed revision became official February 1, 2011 in the Second Supplement to USP 33–NF28 Reissue, but a number of references listing the previous section title were not corrected.

The monographs and General Chapter containing incorrect references will be updated in the First Supplement to USP 35–NF 30. The list of impacted monographs and General Chapter is as follows:

  • <1041> Biologics
  • Flumazenil C 11 Injection
  • Mespiperone C 11 Injection
  • Methionine C 11 Injection
  • Raclopride C 11 Injection
  • Sodium Acetate C 11 Injection
  • Sodium Chromate Cr 51 Injection
  • Chromium Cr 51 Edetate Injection
  • Ciprofloxacin Injection
  • Desmopressin Acetate Injection
  • Famotidine Injection
  • Fludeoxyglucose F 18 Injection
  • Fluorodopa F 18 Injection
  • Sodium Fluoride F 18 Injection
  • Gallium Citrate Ga 67 Injection
  • Indium In 111 Chloride Solution
  • Indium In 111 Pentetate Injection
  • Indium In 111 Pentetreotide Injection
  • Indium In 111 Satumomab Pendetide Injection
  • Iobenguane I 123 Injection
  • Iobenguane I 131 Injection
  • Iodohippurate Sodium I 123 Injection
  • Sodium Iodide I 123 Solution
  • Iodinated I 125 Albumin Injection
  • Iothalamate Sodium I 125 Injection
  • Iodinated I 131 Albumin Injection
  • Iodinated I 131 Albumin Aggregated Injection
  • Iodohippurate Sodium I 131 Injection
  • Rose Bengal Sodium I 131 Injection
  • Sodium Iodide I 131 Solution
  • Ammonia N 13 Injection
  • Water O 15 Injection
  • Chromic Phosphate P 32 Suspension
  • Sodium Phosphate P 32 Solution
  • Rubidium Chloride Rb 82 Injection
  • Samarium Sm 153 Lexidronam Injection
  • Strontium Chloride Sr 89 Injection
  • Technetium Tc 99M Albumin Injection
  • Technetium Tc 99M Albumin Aggregated Injection
  • Technetium Tc 99M Albumin Colloid Injection
  • Technetium Tc 99M Apcitide Injection 3552
  • Technetium Tc 99M Depreotide Injection
  • Technetium Tc 99M Disofenin Injection
  • Technetium Tc 99M Exametazime Injection
  • Technetium Tc 99M Gluceptate Injection
  • Technetium Tc 99M Lidofenin Injection
  • Technetium Tc 99M Mebrofenin Injection
  • Technetium Tc 99M Medronate Injection
  • Technetium Tc 99M Mertiatide Injection
  • Technetium Tc 99M Pentetate Injection
  • Sodium Pertechnetate Tc 99M Injection
  • Technetium Tc 99M Pyrophosphate Injection
  • Technetium Tc 99M (Pyro- and trimeta-) Phosphates Injection
  • Technetium Tc 99M Red Blood Cells Injection
  • Technetium Tc 99M Sestamibi Injection
  • Technetium Tc 99M Succimer Injection
  • Technetium Tc 99M Sulfur Colloid Injection
  • Thallous Chloride Tl 201 Injection
  • Xenon Xe 133 Injection

Should you have any questions, please contact Behnam Davani, Ph.D. (301-816-8394 or or Desmond Hunt, Ph.D. (301-816- 8341 or